TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05315687

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Y-90 SIR-Spheres
Description: Y-90 SIR-Spheres

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Yttrium-90 Microsphere Radioembolization
Description: Undergo Y90 radioembolization

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Systemic Therapy
Description: Systemic Therapy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Systemic Therapy
Description: Systemic Therapy
Study: NCT04737018

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: sham program
Description: a 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation.
Study: NCT05978947

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Density Gradient Centrifugation Method
Description: Density gradient centrifugation is a laboratory technique used to separate and isolate different types of cells or particles based on their density. It is commonly used in various applications, including cell biology, immunology, and assisted reproductive technology (ART).
Study: NCT04783272

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Photoacoustic Computed Tomography (PACT) Imaging
Description: PACT will be completed prior surgery.
Study: NCT06458517

Intervention type: DEVICE
Group type: OTHER
Intervention: Photobiomodulation session - intraoral
Description: use of CareMin650TM lightbox(NeoMedLight) in preventive and in case of occurence of grade 1 oral mucositis, in curative purpose

Intervention type: DEVICE
Group type: OTHER
Intervention: Photobiomodulation session - transcutaneous
Description: use of ATP38® phototherapy device (Swiss Bio Inov Europe) in preventive and in case of occurence of grade 1 oral mucositis, in curative purpose
Study: NCT05791396

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Donor - FMT
Description: this intervention is represented by the administration, in the recipients' gut, of donor microbiota through FMT

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo FMT
Description: This intervention is represented by the administration, in the recipients' gut, of a placebo through colonoscopy
Study: NCT05894447

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naptumomab Estafenatox
Description: 5 or 10 µg/kg IV naptumomab estafenatox will be given on the first four days of every 21-day treatment cycle for 6 cycles

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200 mg IV pembrolizumab will be given on day 2 of each 21 day cycle for up to 24 cycles

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Obinutuzumab
Description: Two doses of 1,000 mg IV obinutuzumab given prior to starting pembrolizumab and naptumomab estafenatox
Study: NCT05072730

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Super High Pressure Balloon (OPN NC)
Description: Strategy of super high-pressure balloon angioplasty after unsuccessful lesion preparation with conventional NC balloon angioplasty.~Optical coherence tomography (OCT) imaging will be performed after lesion preparation with OPN balloon. Optional additional pre-dilatation with OPN/standard NC balloon is permitted at the operator´s discretion. Following lesion preparation, stenting will be performed in the same setting using a latest-generation everolimus-eluting stent (XIENCE; Abbott Vascular, Chicago, IL, USA). Optional post-dilatation with OPN balloon or standard NC balloon is permitted at the operator´s discretion.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intravascular lithotripsy (IVL)
Description: Strategy of IVL after unsuccessful lesion preparation with conventional NC balloon angioplasty.~Optical coherence tomography (OCT) imaging will be performed after lesion preparation with IVL balloon. Optional additional pre-dilatation with standard NC balloon is permitted at the operator´s discretion. Following lesion preparation, stenting will be performed in the same setting using a latest-generation everolimus-eluting stent (XIENCE; Abbott Vascular, Chicago, IL, USA). Optional post-dilatation with standard NC balloon is permitted at the operator´s discretion.
Study: NCT06530212

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SGJIB
Description: sleeve gastrectomy with jejunoileal bypass with anastomosis between the jejunum at about 100 cm from the duodeno-jejunal flexure and the ileum at 250 cm from the ileocaecal junction.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SAS-JB
Description: single anastomosis sleeve jejunal bypass (SAS-JB) with biliary limb equal one third of total intestinal length.
Study: NCT05897606

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Multiviamins and minerals
Description: The intervention group received one capsule of multivitamin and minerals supplements every day, one hour after breakfast, for 12 weeks.

Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT06325826

Intervention type: DIAGNOSTIC_TEST
Intervention: General Evaluation Score (GES)
Description: According to Evaluation of GES scores Patient will be classified into three groups based on GES score low risk group (score ≤6 points), intermediate risk group (score 6-7.5 points), and high-risk group (score \>7.5 points)
Study: NCT06452914

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Semiconductor Embedded Therapeutic Socks
Description: Semiconductor Embedded Therapeutic Socks
Study: NCT06543888

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: passive exoskeleton- assisted gait training programs
Description: Participants will wear an exoskeleton during the training. Each 30-minute Passive exoskeleton-assisted gait training session include range of motion exercise, movement facilitation, strengthening exercise, coordination exercise, and task-oriented training for activities of daily living

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional gait training
Description: Each 30-minute conventional gait training session include range of motion exercise, movement facilitation, strengthening exercise, coordination exercise, and task-oriented training for activities of daily living.
Study: NCT05314465

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Median nerve mobilization
Description: Median nerve mobilization was given 20 oscillations per minute for 3 times \& repeated 3 times with a pause of 1 minute between each sets for 5times/week for 4weeks.
Study: NCT05737251

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PoET
Description: PoET consists of two online-sessions, each 3.5 hours within groups of 30 people. The following lessons regarding positive psychology constructs were conducted (including short information on each construct and specific exercises): happiness, hope, humour, optimism, gratitude, self-efficacy, flow, meaningfulness, forgiveness, spirituality and resilience.
Study: NCT06426901

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Effects of Tan Tui Exercises on Strength and Performance of Football Players.
Description: Tan Tui, Exercises Tan Tui, is a style of traditional Chinese martial art that emphasizes leg techniques, agility, and conditioning. Basic Kicking Drills. Stance Work. Forms (Taolu) Pattern Drills. Conditioning.Sparring (San Shou). This protocol will be implemented by District Physiotherapist who will visit the mentioned Football academies in group session.
Study: NCT05848518

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation program
Description: The participants will be randomly assigned to the experimental groups: supervised endurance rehabilitation program (SEG, n = 30), supervised strength rehabilitation program (SSG, n = 30), supervised concurrent rehabilitation program (SCG, n = 30), and control group (CG, n = 30)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation program
Description: The participants will be randomly assigned to the experimental groups: supervised endurance rehabilitation program (SEG, n = 30), supervised strength rehabilitation program (SSG, n = 30), supervised concurrent rehabilitation program (SCG, n = 30), and control group (CG, n = 30)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation program
Description: The participants will be randomly assigned to the experimental groups: supervised endurance rehabilitation program (SEG, n = 30), supervised strength rehabilitation program (SSG, n = 30), supervised concurrent rehabilitation program (SCG, n = 30), and control group (CG, n = 30)
Study: NCT05335161

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home-based leg heat therapy
Description: The Aquilo system consists of a garment that contains an inner water-circulating pad that is compressed by air bladders. The volume of air inflating the air bladders is pressure-controlled so the garment automatically adjusts to the shape and size of all legs. The touch screen console contains pre-programmed settings for ease of use. After baseline characteristics are established, patients will be provided with the Aquilo device and will be instructed on how to operate the equipment and how to rapidly remove the system if the alarm sounds or if they have any unusual feeling. Patients in both groups will also receive a logbook to record their sessions. Patients will undergo daily home-based leg HT (90 min/day, 7 days/week) for 12 weeks. Water at 42ºC will be perfused through the water-circulating garment for 90 min, with the goal of increasing skin temperature in the calf to \~37ºC.
Study: NCT05913544

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SINTYA
Description: 10-week psychotherapy program consisting of a weekly 1h30 hour group therapy session plus 1 hour individual therapy session
Study: NCT05706103

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Specific skilled motor training
Description: Participants allocated to the skilled motor training group will receive sensorimotor training of the intrinsic muscles of the lumbopelvic region, namely the multifidus, transversus abdominis, and pelvic floor muscles.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General extension training
Description: Participants allocated to the general extension training group will receive general training exercises using the David Back equipment from the Back Unit at Ghent University Hospital
Study: NCT04993001

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Open lung extubation
Description: Before starting emergence from anesthesia, the patient will be transferred to their hospital bed or stretcher and seated at 30 degrees. Secretions from the patients' oropharynx will be suctioned. To prevent the patient from coughing, the anesthetic gas or intravenous agent will be stopped after the transfer and suction procedure are completed. The FiO2 will be maintained at the same level or increased to 50% (minimum FiO2) with a fresh gas flow rate greater than or equal to 10 L.min-1. The ventilation mode will be changed to pressure support. The level of pressure support will be modified by the anesthesiologist to generate the same volumes as with controlled ventilation. The PEEP will be maintained at the same level. The minimum respiratory rate will be reduced by 4 min-1. The inspiratory flow for triggering will be 2 L.min-1.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Conventional extubation
Description: Before starting emergence from anesthesia, the patient will be transferred to his hospital bed or stretcher and kept in the supine position. Secretions from the patients' oropharynx will be suctioned. To prevent the patient from coughing, the anesthetic gas or intravenous agent will be stopped after the transfer and suction procedure are completed. The FiO2 will be increased to 100% with a fresh gas flow rate greater than or equal to 10 L.min-1. The ventilator will be stopped with the APL valve open to atmosphere. The patient will be manually ventilated with the reservoir bag until spontaneous ventilation resumes. Then, the patient may be manually assisted if the treating anesthesiologist deems it necessary.
Study: NCT04467502

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cognitive-behavioral therapy for gambling disorder
Description: 6 sessions of cognitive-behavioral therapy for gambling disorder
Study: NCT06519539

Intervention type: BEHAVIORAL
Intervention: PORTIONS-4 behaviour change strategies
Description: The intervention includes 4 components, including: a portion control tool set previously developed and tested in our laboratory; a supporting guide (physical book) with dietary, activity and behavioural recommendations; a mobile application aligned with the guide; and biweekly telephone calls from the psychologist and/or dietitian.
Study: NCT04745572

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Carbohydrate Diet
Description: Participants randomized to this group will participate in a group-based weight behavioral management program and consume a high carbohydrate (HC) diet. Because this protocol uses a sequential, multiple assignment, randomized trial (SMART) design, response will be assessed at week 4. Responders will continue with their 1st stage assignment for the remainder of the study. Non-responders will be randomized to 2nd stage intervention of either combine HC diet with time-restricted eating (TRE) or HC diet with additional exercise counseling and support.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reduced Carbohydrate Diet
Description: Participants randomized to this group will participate in a group-based behavioral weight management program and consume a reduced carbohydrate (RC) diet. Because this is a sequential, multiple assignment, randomized trial (SMART) design, response will be assessed at week 4. Responders will continue with their 1st stage assignment for the remainder of the study. Non-responders will be randomized to 2nd stage intervention of either combine RC diet with time-restricted eating (TRE) or RC diet with additional exercise counseling and support.
Study: NCT05947981

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Dextrose 5%, normal saline
Description: Decrease fasting hours

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Dextrose 5%, normal saline
Description: Decrease fasting hours
Study: NCT06506526

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sodium hypochlorite irrigating solution
Description: 2 ml 1% NaOCl after each file

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: one minute NaOCL+Chitosan
Description: 2 ml 1% NaOCl after each file then with 5 ml of 0.2% chitosan for one minute.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Three minute NaOCL+Chitosan
Description: 2 ml 1% NaOCl after each file then with 5 ml of 0.2% chitosan for three minute.
Study: NCT04369040

Intervention type: DEVICE
Group type: OTHER
Intervention: High-flow nasal oxygen therapy using a specific nasal cannula
Description: Patient in this arm will received high-flow nasal oxygen therapy ventilation during the ENT surgery

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flow Controlled Ventilation using a laryngeal tri-tube
Description: Patient in this arm will received a laryngeal tri-tube ventilation during the ENT surgery
Study: NCT05499052

Intervention type: DRUG
Intervention: REKOVELLE®
Description: Subjects must be treated according to the routine clinical practice and REKOVELLE® must be prescribed in accordance with the terms of the marketing authorisation of each participating country.~According to the label the REKOVELLE® dose should be based on a recent determination of body weight and a recent determination of Anti-Müllerian Hormone (AMH) (i.e. within the last 12 months) measured by the following diagnostic tests: ELECSYS AMH Plus immunoassay from Roche or alternatively the ACCESS AMH Advanced from Beckman Coulter or LUMIPULSE G AMH from Fujirebio.
Study: NCT05002738

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Desogestrel and Ethinyl Estradiol Tablets
Description: Combined oral contraceptive pill
Study: NCT06520488

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-4642
Description: Treatment group Part I: HRS-4642 combined with SHR-A1921 Treatment group Part II: HRS-4642 combined with SHR-A1904 Treatment group Part II: HRS-4642 combined with AG
Study: NCT06519201

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SRT with SpineCare
Description: Korean medicine doctors performed the treatment regimens.The TG underwent SRT with SpineCare. Treat-ment was administered for six consecutive weeks, with sessions held twice per week dur-ing the first four weeks and once per week during the final two weeks. No additional treatments (e.g., procedures or surgeries) were allowed during the six-week period. To an-alyze pain according to the number of treatment sessions, a counselor assessed patients using the NRS after each of the ten treatment sessions. To compare the differences in Cobb's angle between the groups, X-rays were performed after the first and tenth treatment sessions. Detailed records of adverse events were maintained before and after each treat-ment session.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SRT without SpineCare
Description: Korean medicine doctors performed the treatment regimens. The CG underwent SRT without SpineCare. Treat-ment was administered for six consecutive weeks, with sessions held twice per week dur-ing the first four weeks and once per week during the final two weeks. No additional treatments (e.g., procedures or surgeries) were allowed during the six-week period. To an-alyze pain according to the number of treatment sessions, a counselor assessed patients using the NRS after each of the ten treatment sessions. To compare the differences in Cobb's angle between the groups, X-rays were performed after the first and tenth treatment sessions. Detailed records of adverse events were maintained before and after each treat-ment session.
Study: NCT05406466

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: a PD-1 immune check inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: multitargeted receptor tyrosine kinase inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cryoablation
Description: Cryoablation will be performed with a two-cycle freeze-thaw phase protocol; US or non-contrast CT images will be obtained to visualize the evolving ablation zone
Study: NCT05790252

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buprenorphine Transdermal Matrix Patch
Description: Buprenorphine transdermal patches will be applied at time of induction initiation and removed at 48 hours.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham patch
Description: Bandage applied at time of induction initiation and removed at 48 hours.
Study: NCT06452914

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Socks
Description: Socks not containing the Semiconductor Embedded Therapeutic fabric
Study: NCT04467502

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: cognitive-behavioral therapy for gambling disorder
Description: 6 sessions of cognitive-behavioral therapy for gambling disorder

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: imaginal exposure therapy focus on gambling cues
Description: 6 sessions of imaginal exposure therapy focus on gambling cues

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: virtual reality exposure therapy focus on gambling cues
Description: 6 sessions of virtual reality exposure therapy focus on gambling cues
Study: NCT06536478

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: 50 minutes of exercise twice a week, including stretching, core exercises, gross motor movements and balance exercises for 5 weeks

Intervention type: OTHER
Group type: OTHER
Intervention: education
Description: The patient will be given a one-time exercise education session and a 50-minute video that included stretching, core exercises, gross motor movements and balance exercises that could be practiced at home.
Study: NCT06052293

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANG003
Description: To evaluate four possible combinations of lipase, protease and amylase.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANG003
Description: To evaluate four possible combinations of lipase, protease and amylase.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANG003
Description: To evaluate four possible combinations of lipase, protease and amylase.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANG003
Description: To evaluate four possible combinations of lipase, protease and amylase.
Study: NCT05357599

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: EUS
Description: The decision to start a beta-blocker will be made at the conclusion of the EGD based on the endoscopic findings (presence of esophageal varices)
Study: NCT04621604

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blood samples
Description: Extra blood samples will be collected during chemotherapy administration to analyze pharmacokinetics of the iPD1
Study: NCT06185140

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cardiac rehabilitation program
Description: Cardiac rehabilitation program

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TELEA platform
Description: TELEA platform
Study: NCT04679116

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Laparoscopic bilateral inguinal hernia repair
Description: Laparoscopic bilateral inguinal hernia repair

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Open bilateral inguinal hernia repair
Description: Open bilateral inguinal hernia repair
Study: NCT04924465

Intervention type: OTHER
Intervention: Follow-up
Description: Follow-up of clinical data, laboratory tests, radiological data and pulmonary function tests

Intervention type: OTHER
Intervention: Follow-up
Description: Follow-up of clinical data, laboratory tests, radiological data and pulmonary function tests

Intervention type: OTHER
Intervention: Follow-up
Description: Follow-up of clinical data, laboratory tests, radiological data and pulmonary function tests

Intervention type: OTHER
Intervention: Follow-up
Description: Follow-up of clinical data, laboratory tests, radiological data and pulmonary function tests

Intervention type: OTHER
Intervention: Follow-up
Description: Follow-up of clinical data, laboratory tests, radiological data and pulmonary function tests
Study: NCT05991401

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-8010 5mg
Description: \[Period 1\] DA-8010 5mg \[Period 2\] DA-8010 5mg, Clarithromycin 500mg \[Period 3\] DA-8010 5mg, Rifampicin 600mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarithromycin 500mg
Description: \[Period 2\] DA-8010 5mg, Clarithromycin 500mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampicin 600mg
Description: \[Period 3\] DA-8010 5mg, Rifampicin 600mg